Vanessa Ragaglia
Corporate Officer/Principal presso Garnet BioTherapeutics, Inc.
Posizioni attive di Vanessa Ragaglia
Società | Posizione | Inizio | Fine |
---|---|---|---|
Garnet BioTherapeutics, Inc.
Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Corporate Officer/Principal | 01/01/2000 | - |
Direttore Tecnico/Scientifico/R&S | 01/01/2000 | - | |
Celebration Stem Cell Centre | Corporate Officer/Principal | - | - |
Storia della carriera di Vanessa Ragaglia
Formazione di Vanessa Ragaglia
The Ohio State University College of Medicine | Doctorate Degree |
Trinity College (Connecticut) | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Settori
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Garnet BioTherapeutics, Inc.
Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Commercial Services |
Celebration Stem Cell Centre |
- Borsa valori
- Insiders
- Vanessa Ragaglia
- Esperienza